-
+18 +3
‘You don’t want to get better’: the outdated treatment of ME/CFS patients is a national scandal
The notion that this illness is psychosomatic is having devastating effects, says Guardian columnist George Monbiot
-
+29 +2
Micro- and nanoplastics in the body are passed on during cell division
Scientists investigated effects of tiny plastic particles on cancer cells in the human gastrointestinal tract, finding they are passed on to newly formed cells during cell division, and could promote the metastasis of tumours.
-
+25 +2
Spontaneous Smoking Cessation Before Lung Cancer Diagnosis
We have observed that many patients with lung cancer stop smoking before diagnosis, usually before clinical symptoms, and often without difficulty. This led us to speculate that spontaneous smoking cessation may be a presenting symptom of lung cancer.
-
+24 +4
One Simple Change May Dramatically Boost The Effect of COVID-19 Vaccines
Sometimes it's the simplest solutions that get lost in the kerfuffle of scientific progress.
-
+30 +6
The nocebo effect? Six surprising things about placebos everyone should know
Even though placebos have been widely studied, there are still many things about them that will surprise you.
-
+30 +7
Oreo Study with Nick Norwitz and Dr. William Cromwell [Oreos better than Crestor?]
-
+36 +5
Cancer vaccine with minimal side effects nearing Phase 3 clinical trials
Dr. Thomas Wagner, founder of the biotech company Orbis Health Solutions and cancer researcher, has made it his life's mission to find a way to treat cancer without the dreaded side effects that, for some, can become worse than the cancer itself or may even lead to an earlier death. "The tragedy of cancer is not just that person, the diagnosis, but it's also the fear of the therapy," Wagner told ABC News. This can cause a range of side effects including hair loss, nausea, vomiting, or may knock out a person's immune system putting them at risk of life-threatening infections, Wagner said.
-
+35 +5
Heart Failure - Do statins help or hurt?
-
+32 +6
The new drugs that may bring an end to constant itching
While for most people, an itch is an annoying, temporary nuisance, one in five of us will experience chronic itch lasting weeks or months. New treatments finally offer hope.
-
+36 +4
Your pacemaker and open source software
Using embedded medical technology, such as a pacemaker, defibrillator, or insulin pump? What's running inside is a complete mystery
-
+38 +6
You Know It’s a Placebo. So Why Does It Still Work?
As researchers try to make sense of “open-label” placebos—fake drugs that proudly announce their fakeness—the mysterious effect is starting to show up beyond the world of medicine.
-
+36 +8
The 8 Things Causing Illness Most Doctors Can't Treat | Dr. Robert Lustig
-
+32 +3
Knock Knock Eye: Snowstorm Hallucinations
-
+23 +4
I reversed my type 2 diabetes. Here’s how I did it | Neil Barsky
Modern medicine makes it seem as if drugs are the only way to deal with diabetes. But what if diet can be a solution?
-
+56 +14
A Man Ate 600 Pounds Instant Noodles Over 6 Months. This Is What Happened To His Gut.
-
+53 +8
Scientists Have Finally Figured Out What Ignites Endless Itching in Eczema
The unbearable itch that accompanies the chronic inflammatory skin condition eczema has a new culprit.
-
+37 +5
Ubiquitous nanoplastics found to cause Parkinson’s disease
New research is finding that nanoplastics aggregate in the brain causing certain forms of dementia.
-
+39 +7
Where Do Millions of Snakes Disappear to?
-
+46 +8
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension - Recor Medical
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S. Palo Alto, Calif. – November 7, 2023 – Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise™ Ultrasound...
-
+30 +5
World's Leading Theory on Alzheimer's in Crisis After Major Drug Trials Fail
These drugs significantly reduce the amount of amyloid beta in the brain as intended, but this did not translate into improvements in cognitive function.
Submit a link
Start a discussion